Document:

EX-4.1

 

Exhibit 4.1

Execution Copy

AMENDMENT No. 4 TO RIGHTS AGREEMENT

     This Amendment No. 4, dated as of February 16, 2006 (this “Amendment”), to the Rights
Agreement, dated as of June 15, 1998 (as amended by Amendment Nos. 1, 2 and 3 thereto, the “Rights
Agreement”), is entered into by and between IMS Health Incorporated, a Delaware corporation (the
“Company”), and Computershare Trust Company, N.A., formerly known as First Chicago Trust Company of
New York and EquiServe Trust Company, N.A., as Rights Agent (the “Rights Agent”). Capitalized terms
used in this Amendment but not otherwise defined herein shall have the meanings ascribed to them in
the Rights Agreement.

          WHEREAS, the Company desires to amend the Rights Agreement to advance the Final Expiration
Date of the Rights to the close of business on February 16, 2006;

          WHEREAS, the Company deems this Amendment to be necessary and desirable and in the best
interests of the holders of Rights and has duly approved this Amendment;

          WHEREAS, Section 27 of the Rights Agreement permits the Company to amend the Rights Agreement
in the manner provided herein;

          WHEREAS, Section 27 of the Rights Agreement provides that the Rights Agent shall execute this
Amendment upon delivery of a certificate from an appropriate officer of the Company which states
that this Amendment is in compliance with the terms of Section 27 of the Rights Agreement (the
“Officer’s Certificate”); and

          WHEREAS, the Officer’s Certificate is being delivered to the Rights Agent concurrently with
this Amendment.

          NOW, THEREFORE, the Company hereby amends the Rights Agreement as follows:

     1. Clause (i) of Section 7(a) of the Rights Agreement is hereby amended to replace the words
“June 30, 2008” with the words “February 16, 2006.”

     2. Exhibit B to the Rights Agreement entitled “Form of Right Certificate” is hereby amended
to replace the words “June 30, 2008” with the words “February 16, 2006” in all places where such
words appear.

     3. Exhibit C to the Rights Agreement entitled “Summary of Rights Plan” is hereby amended to
replace the words “June 30, 2008” with the words “February 16, 2006” in all places where such words
appear.

 

 

     4. Except as expressly set forth herein, the Rights Agreement shall remain in full force and
effect and otherwise shall be unaffected by this Amendment.

     5. This Amendment may be executed in any number of counterparts, each of which, when
executed, shall be an original and all such counterparts shall together constitute one and the same
document.

 

 

     IN WITNESS WHEREOF, the parties have executed this Amendment as of the date first written
above.

	 	 	 	 	 
	             IMS HEALTH INCORPORATED

 	 
	 	By:  	/s/ Robert H. Steinfeld
 	 
	 	 	Name:  	Robert H. Steinfeld 	 
	 	 	Title:  	Senior Vice President,
 General
Counsel and Corporate
Secretary 
	 

	 	 	 	 	 
	                                       COMPUTERSHARE TRUST COMPANY, N.A.

 	 
	 	By:  	/s/ Anthony Milo
 	 
	 	 	Name:  	Anthony Milo 	 
	 	 	Title:  	Managing DirectorEX-4.5:

 

Exhibit 4.5

Execution Copy

AMENDMENT No. 4 TO RIGHTS AGREEMENT

     This Amendment No. 4, dated as of February 16, 2006 (this “Amendment”), to the Rights
Agreement, dated as of June 15, 1998 (as amended by Amendment Nos. 1, 2 and 3 thereto, the “Rights
Agreement”), is entered into by and between IMS Health Incorporated, a Delaware corporation (the
“Company”), and Computershare Trust Company, N.A., formerly known as First Chicago Trust Company of
New York and EquiServe Trust Company, N.A., as Rights Agent (the “Rights Agent”). Capitalized terms
used in this Amendment but not otherwise defined herein shall have the meanings ascribed to them in
the Rights Agreement.

          WHEREAS, the Company desires to amend the Rights Agreement to advance the Final
Expiration Date of the Rights to the close of business on February 16, 2006;

          WHEREAS, the Company deems this Amendment to be necessary and desirable and in the best
interests of the holders of Rights and has duly approved this Amendment;

          WHEREAS, Section 27 of the Rights Agreement permits the Company to amend the Rights Agreement
in the manner provided herein;

          WHEREAS, Section 27 of the Rights Agreement provides that the Rights Agent shall execute this
Amendment upon delivery of a certificate from an appropriate officer of the Company which states
that this Amendment is in compliance with the terms of Section 27 of the Rights Agreement (the
“Officer’s Certificate”); and

          WHEREAS, the Officer’s Certificate is being delivered to the Rights Agent concurrently with
this Amendment.

          NOW, THEREFORE, the Company hereby amends the Rights Agreement as follows:

     1. Clause (i) of Section 7(a) of the Rights Agreement is hereby amended to replace the
words “June 30, 2008” with the words “February 16, 2006.”

     2. Exhibit B to the Rights Agreement entitled “Form of Right Certificate” is hereby amended
to replace the words “June 30, 2008” with the words “February 16, 2006” in all places where such
words appear.

     3. Exhibit C to the Rights Agreement entitled “Summary of Rights Plan” is hereby amended to
replace the words “June 30, 2008” with the words “February 16, 2006” in all places where such words
appear.

 

 

     4. Except as expressly set forth herein, the Rights Agreement shall remain in full force and
effect and otherwise shall be unaffected by this Amendment.

     5. This Amendment may be executed in any number of counterparts, each of which, when
executed, shall be an original and all such counterparts shall together constitute one and the same
document.

 

 

     IN WITNESS WHEREOF, the parties have executed this Amendment as of the date first written
above.

	 	 	 	 	 	 	 	 	 	 	 
	 	 	IMS HEALTH INCORPORATED	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	By:	 	     /s/ Robert H. Steinfeld	 	 
	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Name:
	 	Robert H. Steinfeld	 	 
	 

	 	 	 	 	 	Title:
	 	Senior Vice President, General	 	 
	 

	 	 	 	 	 	 	 	Counsel and Corporate	 	 
	 

	 	 	 	 	 	 	 	Secretary	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	COMPUTERSHARE TRUST COMPANY, N.A.	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	By:	 	     /s/ Anthony Milo	 	 
	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Name:
	 	Anthony Milo	 	 
	 

	 	 	 	 	 	Title:
	 	Managing Directorexv10w1

 

Exhibit 10.1

STOCK PURCHASE AND SALE AGREEMENT

          This STOCK PURCHASE AND SALE AGREEMENT (the “Agreement”) is made and entered into as
of this 16th day of February, 2006, by and between the W.K. Kellogg Foundation Trust, a charitable
trust organized under the laws of the State of Michigan (the “Selling Stockholder”), and
Kellogg Company, a Delaware corporation (the “Company”).

          WHEREAS, the Company repurchased from the Selling Stockholder 9,371,567 Shares (as defined
below) owned by the Selling Stockholder, for an aggregate purchase price of $400 million in cash,
pursuant to a Stock Purchase and Sale Agreement dated as of November 8, 2005 (the “2005 Agreement”)
under which the Selling Stockholder granted the Company certain rights with respect to the
purchase of certain additional Shares of the Selling Stockholder in the event the Selling
Stockholder desired to dispose of such Shares under certain circumstances and the Company granted
the Selling Stockholder certain registration rights with respect to such additional Shares.

          WHEREAS, the Selling Stockholder desires to dispose of additional Shares, the Company has
agreed to repurchase from the Selling Stockholder such additional Shares and the Selling
Stockholder has agreed to relinquish the registration rights granted under the 2005 Agreement.

          WHEREAS, as of January 27, 2006, the Company had issued and there were outstanding 405,472,156
shares of common stock, par value $.0l per share (the “Shares”).

          WHEREAS, the Selling Stockholder currently owns 109,288,673 Shares, constituting
approximately 27% of the outstanding Shares.

          NOW, THEREFORE, in consideration of the foregoing and the mutual representations, warranties,
covenants and agreements set forth in this Agreement, the parties agree as follows:

ARTICLE I

Purchase and Sale

          1.1       Purchase of Shares. On the terms and subject to the conditions of this Agreement,
at the Closing, the Selling Stockholder shall sell, assign, transfer and deliver to the Company,
and the Company shall acquire from the Selling Stockholder, 12,784,751 Shares owned by the Selling
Stockholder (the “Purchased Shares”), in exchange for cash in an aggregate amount equal to
$550 million (the “Purchase Price”), representing a per Share purchase price of $43.02.

ARTICLE II

The Closing

          2.1      Closing; Closing Deliveries. (a) Subject to clause (d) below, the closing shall
take place on February 21, 2006 at a time mutually agreed by the parties at the offices of the
Company (the “Closing”).

 

 

          (b)      At the Closing, the Selling Stockholder shall cause the Purchased Shares to be transferred
to the Company (and such transfer to be reflected on the share registry of the Company) free and
clear of all liens, claims, security interests, pledges, charges and other encumbrances.

          (c)      At the Closing, the Company shall deliver by wire transfer to the account designated by
the Selling Stockholder and set forth on Schedule 2.1 immediately available funds in U.S. dollars
in an amount equal to the Purchase Price.

          (d)      The obligations of the parties hereto to consummate the transaction contemplated hereby
shall be subject to the satisfaction at the Closing of the condition that there shall be no
statute, regulation, injunction, restraining or other order, rule or decree of any nature of any
local, state, federal or foreign court, arbitrator, arbitral tribunal, or other governmental,
administrative or regulatory entity, agency, instrumentality or authority (collectively, a
“Governmental Authority”) that is in effect that prohibits, restricts, alters or prevents
consummation of the transaction contemplated hereby.

ARTICLE III

Representations and Warranties of the Company

          In order to induce the Selling Stockholder to enter into this Agreement, the Company hereby
represents and warrants to the Selling Stockholder as follows:

          3.1      Corporate Power and Authority. The Company is duly organized, validly existing
and in good standing under the laws of the State of Delaware. The Company has all requisite
corporate power and authority to enter into and deliver this Agreement, to perform its obligations
hereunder and to consummate the transaction contemplated by this Agreement. The execution,
delivery and performance of this Agreement by the Company have been duly authorized by all
necessary corporate action on the part of the Company. This Agreement has been duly executed and
delivered by the Company and (assuming due authorization, execution and delivery by the Selling
Stockholder) constitutes the legal, valid and binding obligation of the Company enforceable against
the Company in accordance with its terms subject to (a) applicable bankruptcy, insolvency,
fraudulent conveyance and other similar laws and (b) general principles of equity, including
equitable defenses and limits as to the availability of equitable remedies, whether such principles
are considered in a proceeding at law or in equity.

          3.2       Conflicts; Consents and Approvals. To the knowledge of the General Counsel and
Chief Financial Officer of the Company as of the date hereof, the execution and delivery of this
Agreement and the consummation of the transaction contemplated by this Agreement do not and will
not (a) violate, conflict with, or result in a breach of any provision of, or constitute a default
under, the Company’s Amended Restated Certificate of Incorporation or Bylaws, as amended; (b)
violate any order, writ, injunction, decree, statute, rule or regulation applicable to the Company;
or (c) require any action or consent or approval of, or review by, or registration or material
filing by the Company with, any Governmental Authority, except as set forth herein and the filing
of a Current Report on Form 8-K.

-2-

 

          3.3       Litigation. As of the date immediately preceding the date hereof, to the
knowledge of the General Counsel and Chief Financial Officer of the Company, there are no actions,
suits or proceedings pending against the Company (or any of its properties, rights or franchises),
at law or in equity, or before any Governmental Authority that would, individually or in the
aggregate, reasonably be expected to have an adverse effect on its ability to consummate the
transaction contemplated hereby.

ARTICLE IV

Representations and Warranties of the Selling Stockholder

          In order to induce the Company to enter into this Agreement, the Selling Stockholder
represents and warrants to the Company as follows:

          4.1       Title to Shares. The Selling Stockholder owns beneficially and of record the
Purchased Shares and has good title, free and clear of all liens, claims, security interests,
pledges, charges and other encumbrances, to the Purchased Shares.

          4.2      Power and Authority. The Selling Stockholder is duly organized and validly
existing under the laws of the State of Michigan. It has all requisite power and authority to
enter into and deliver this Agreement, to perform its obligations hereunder and to consummate the
transaction contemplated by this Agreement. The execution, delivery and performance of this
Agreement by the Selling Stockholder has been duly authorized by all necessary action on its part.
This Agreement has been duly executed and delivered by the Selling Stockholder and (assuming due
authorization, execution and delivery by the Company) constitutes the legal, valid and binding
obligation of the Selling Stockholder, enforceable against it in accordance with its terms subject
to (a) applicable bankruptcy, insolvency, fraudulent conveyance and other similar laws and (b)
general principles of equity, including equitable defenses and limits as to the availability of
equitable remedies, whether such principles are considered in a proceeding at law or in equity.

          4.3      Conflicts; Consents and Approvals. To the knowledge of the Trustees of the
Selling Stockholder as of the date hereof, the execution and delivery of this Agreement and the
consummation of the transaction contemplated by this Agreement do not and will not (a) violate,
conflict with, or result in a breach of any provision of, or constitute a default under, the
Selling Stockholder’s governing or organizational documents; (b) violate any order, writ,
injunction, decree, statute, rule or regulation applicable to the Selling Stockholder; or (c)
require any action or consent or approval of, or review by, or registration or material filing,
other than a filing pursuant to Section 16(a) under the Securities Exchange Act of 1934, as
amended, by it with, any Governmental Authority except as set forth herein.

          4.4      No Agreements or Understandings. The Selling Stockholder is not a party to any
contract, agreement, arrangement, understanding or relationship (legal or otherwise) with any other
person, individual, firm, corporation, partnership, trust, joint venture, governmental authority or
other entity with respect to any securities of the Company, including without limitation transfer
or voting of any securities of the Company, finders fees, joint ventures, loan or option
arrangements, puts or calls, guarantees of profits, division of profits or losses or the giving or
withholding of proxies.

-3-

 

          4.5      Litigation. As of the date immediately preceding the date hereof, to the
knowledge of the Trustees of the Selling Stockholder, there are no actions, suits or proceedings
pending against the Selling Stockholder (or any of its properties, rights or franchises), at law or
in equity, or before any Governmental Authority that would, individually or in the aggregate,
reasonably be expected to have an adverse effect on its ability to consummate the transaction
contemplated hereby.

ARTICLE V

Additional Covenants

          5.1      Press Releases. The initial press release by each of the Selling Stockholder and
the Company announcing the transaction contemplated by this Agreement shall be in the form mutually
agreed by the parties.

          5.2      Transfer Taxes. The Selling Stockholder shall be responsible for the payment of
any stock transfer or similar taxes in connection with the transaction contemplated by this
Agreement.

          5.3       Further Assurances. (a) Each of the parties hereto shall use its reasonable best
efforts to take, or cause to be taken, all appropriate action, to do or cause to be done all things
necessary, proper or advisable under applicable law, and to execute and deliver such documents and
other papers, as may be required to carry out the provisions of this Agreement and to consummate
and make effective the transaction contemplated by this Agreement.

          (b)      Each of the Company and the Selling Stockholder agrees to cooperate and use its reasonable
best efforts to contest and resist any action, including, without limitation, administrative or
judicial action, and to have vacated, lifted, reversed or overturned any decree, judgment,
injunction or other order (whether temporary, preliminary or permanent) that is in effect that
restricts, prevents or prohibits the consummation of the transaction contemplated by this
Agreement, including, without limitation, by pursuing all reasonably available avenues of
administrative and judicial appeal.

ARTICLE VI

Miscellaneous

          6.1      Counterparts. This Agreement may be executed in any number of counterparts, which
together shall constitute one and the same Agreement. The parties may execute more than one copy
of the Agreement, each of which shall constitute an original.

          6.2       Entire Agreement. This Agreement (including Schedule 2.1) constitutes the entire
agreement between the parties and supersedes all prior agreements, understandings, arrangements or
representations by or between the parties, written and oral, with respect to the subject matter
hereof. The parties hereby agree that they shall have no further rights, obligations, liabilities
or claims under or relating to any such other agreement and, in particular, agree that the sale and
acquisition of the Purchased Shares at the Closing shall extinguish any and all rights

-4-

 

and obligations that either party may have under Section 5.2 and Exhibit A of the 2005
Agreement.

          6.3       Third Party Beneficiaries. Nothing in this Agreement, express or implied, is
intended or shall be construed to create any third party beneficiaries.

          6.4       Governing Law; Jurisdiction. This Agreement shall be governed by the laws of the
State of Delaware, without giving effect to the conflict of laws principles thereof. Each party
irrevocably and unconditionally consents to submit to the exclusive jurisdiction of the courts of
the State of Delaware and of the United States of America, in each case located in the State of
Delaware, for any action or proceeding arising out of or relating to this Agreement and the
transaction contemplated by this Agreement (and agrees not to commence any action except in any
such court). Each party irrevocably and unconditionally waives any objection to the laying of
venue of any action or proceeding in the courts of the State of Delaware or of the United States of
America, in each case located in the State of Delaware, and further irrevocably and unconditionally
waives and agrees not to plead or claim in any such court that any action or proceeding brought in
any such court has been brought in an inconvenient forum. Each party irrevocably and
unconditionally waives any right it may have to a trial by jury in connection with any action or
proceeding arising out of or relating to this Agreement and the transaction contemplated by this
Agreement.

          6.5      Specific Performance. The transaction contemplated by this Agreement is unique.
Accordingly, each of the parties acknowledges and agrees that, in addition to all other remedies to
which it may be entitled, each of the parties hereto is entitled to a decree of specific
performance and injunctive and other equitable relief.

          6.6 Amendment. This Agreement may not be altered, amended or supplemented except by
an agreement in writing signed by each of the parties hereto.

          6.7       Notices. All notices, requests, claims, demands and other communications
hereunder shall be in writing and shall be given or made (and shall be deemed to have been duly
given or made upon receipt) by delivery in person, by facsimile, by courier service or by
registered or certified mail to the respective parties at the following addresses (or at such other
address for a party as shall be specified in a notice given in accordance with this Section 6.7):

	 	 	 
	 

	 	If to the Selling Stockholder, to:
	 
	 	 
	 

	 	W.K. Kellogg Foundation Trust
	 

	 	c/o The Bank of New York
	 

	 	1633 Broadway, 13th Floor
	 

	 	New York, New York 10019
	 

	 	Attention: Kevin J. Bannon
	 

	 	Facsimile No.: (212) 237-0936
	 
	 

	 	With a copy to:

-5-

 

	 	 	 
	 

	 	Sidley Austin LLP
	 

	 	One South Dearborn Street
	 

	 	Chicago, Illinois 60603
	 

	 	Attention: Paul A. Svoboda, Esq.
	 

	 	Facsimile No.: (312) 853-7036
	 
	 	 
	 

	 	if to the Company, to:
	 
	 	 
	 

	 	Kellogg Company
	 

	 	One Kellogg Square
	 

	 	Battle Creek, Michigan 49017
	 

	 	Attention: Chief Financial Officer
	 

	 	Facsimile No.: (269) 961-6598
	 
	 	 
	 

	 	With copies to:
	 
	 	 
	 

	 	Kellogg Company
	 

	 	One Kellogg Square
	 

	 	Battle Creek, Michigan 49017
	 

	 	Attention: General Counsel
	 

	 	Facsimile No.: (269) 565-1266
	 
	 	 
	 

	 	Wachtell, Lipton, Rosen & Katz
	 

	 	51 West 52nd Street
	 

	 	New York, New York 10019
	 

	 	Attention: Daniel A. Neff, Esq.
	 

	 	Facsimile No.: (212) 403-2218

          6.8       Assignment. Neither this Agreement nor any of the rights, interests or
obligations hereunder shall be assigned by either of the parties (whether by operation of law or
otherwise) without the prior written consent of the other party. Subject to the preceding
sentence, this Agreement shall be binding upon, inure to the benefit of and be enforceable by the
parties and their respective successors and assigns.

          6.9      Fees and Expenses. Except as otherwise provided in this Agreement, all costs and
expenses incurred in connection with this Agreement and the transaction contemplated by this
Agreement shall be the responsibility of and shall be paid by the party incurring such fees or
expenses, whether or not the transaction contemplated by this Agreement is consummated.

          [REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]

-6-

 

          IN WITNESS WHEREOF, each of the undersigned has caused this Agreement to be executed by its
officer thereunto duly authorized as of the date first written above.

	 	 	 	 	 	 	 
	 	 	W.K. KELLOGG FOUNDATION TRUST	 	 
	 
	 	 	 	 	 	 
	 	 	By: The Bank of New York, corporate trustee	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Kevin J. Bannon	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Name: Kevin J. Bannon

	 	 
	 
	 	 	 	Title: Executive Vice President	 	 
	 
	 	 	 	 	 	 
	 	 	KELLOGG COMPANY	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Jeffrey M. Boromisa	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Name Jeffrey M. Boromisa

Title: Senior Vice President and Chief Financial
Officer	 	 

A-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}]]